Deep proteomic analysis of obstetric antiphospholipid syndrome by DIA-MS of extracellular vesicle enriched fractions

Commun Biol. 2024 Jan 15;7(1):99. doi: 10.1038/s42003-024-05789-3.

Abstract

Proteins in the plasma/serum mirror an individual's physiology. Circulating extracellular vesicles (EVs) proteins constitute a large portion of the plasma/serum proteome. Thus, deep and unbiased proteomic analysis of circulating plasma/serum extracellular vesicles holds promise for discovering disease biomarkers as well as revealing disease mechanisms. We established a workflow for simple, deep, and reproducible proteome analysis of both serum large and small EVs enriched fractions by ultracentrifugation plus 4D-data-independent acquisition mass spectrometry (4D-DIA-MS). In our cohort study of obstetric antiphospholipid syndrome (OAPS), 4270 and 3328 proteins were identified from large and small EVs enriched fractions respectively. Both of them revealed known or new pathways related to OAPS. Increased levels of von Willebrand factor (VWF) and insulin receptor (INSR) were identified as candidate biomarkers, which shed light on hypercoagulability and abnormal insulin signaling in disease progression. Our workflow will significantly promote our understanding of plasma/serum-based disease mechanisms and generate new biomarkers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiphospholipid Syndrome* / metabolism
  • Biomarkers
  • Cohort Studies
  • Extracellular Vesicles* / metabolism
  • Female
  • Humans
  • Pregnancy
  • Proteome / metabolism
  • Proteomics / methods

Substances

  • Proteome
  • Biomarkers